BEX2, part of the BEX gene family, was found to be silenced in U-87 and primary glioma cell lines, with its re-expression increasing sensitivity to chemotherapy-induced apoptosis and demonstrating tumor suppressor effects [51]. This evidence concerns the gene BEX2 and central nervous system cancer.